Dana E. Rathkopf

2007–2026 年に発表

91
論文数
27,059
被引用数
54
h 指数
86
i10 指数

被引用数

Dana E. Rathkopf の年別被引用数1992 年: 被引用 1 件1994 年: 被引用 1 件1999 年: 被引用 1 件2003 年: 被引用 1 件2004 年: 被引用 1 件2007 年: 被引用 1 件2009 年: 被引用 6 件2010 年: 被引用 15 件2011 年: 被引用 51 件2012 年: 被引用 35 件2013 年: 被引用 82 件2014 年: 被引用 142 件2015 年: 被引用 225 件2016 年: 被引用 275 件2017 年: 被引用 340 件2018 年: 被引用 443 件2019 年: 被引用 1,143 件2020 年: 被引用 1,310 件2021 年: 被引用 1,440 件2022 年: 被引用 1,119 件2023 年: 被引用 903 件2024 年: 被引用 1,511 件2025 年: 被引用 712 件2026 年: 被引用 27 件1993 年は被引用が無いため表示していません1995〜1998 年は被引用が無いため表示していません2000〜2002 年は被引用が無いため表示していません2005〜2006 年は被引用が無いため表示していません2008 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,452 件、この内訳の 26.8%中国: 引用元論文 1,249 件、この内訳の 9.7%イギリス: 引用元論文 824 件、この内訳の 6.4%ドイツ: 引用元論文 667 件、この内訳の 5.2%カナダ: 引用元論文 646 件、この内訳の 5%イタリア: 引用元論文 624 件、この内訳の 4.9%フランス: 引用元論文 493 件、この内訳の 3.8%オーストラリア: 引用元論文 423 件、この内訳の 3.3%スペイン: 引用元論文 408 件、この内訳の 3.2%日本: 引用元論文 382 件、この内訳の 3%オランダ: 引用元論文 368 件、この内訳の 2.9%スイス: 引用元論文 339 件、この内訳の 2.6%
0%26.8%その他 23.2%

分野

  • Medicine67.5%
  • Biochemistry, Genetics and Molecular Biology26.6%
  • Immunology and Microbiology2%
  • Engineering1.4%
  • Computer Science1%
  • Chemistry0.2%
  • その他1.3%

トピック

  • Prostate Cancer Treatment and Research16.2%
  • Prostate Cancer Diagnosis and Treatment7%
  • Cancer Genomics and Diagnostics5.9%
  • Radiopharmaceutical Chemistry and Applications3.9%
  • Cancer Cells and Metastasis3.3%
  • Cancer, Lipids, and Metabolism2.8%
  • その他60.9%

共著者

全論文

検索で開く
  1. OncoKB: A Precision Oncology Knowledge Base

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio Omuro, Michael A. Postow, Dana E. Rathkopf, Alexander N. Shoushtari, Neerav Shukla, Martin H. Voss, Ederlinda Paraiso, Ahmet Zehir, Michael F. Berger, Barry S. Taylor, Leonard B. Saltz, Gregory J. Riely, Marc Ladanyi, David M. Hyman, José Baselga, Paul Sabbatini, David B. Solit, Nikolaus Schultz - JCO Precision Oncology 2017 被引用: 2,698

  2. Integrative Clinical Genomics of Advanced Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 被引用: 3,701

  3. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter S. Nelson, Lawrence H. Schwartz, Susan Halabi, Philip W. Kantoff, Andrew J. Armstrong - Journal of Clinical Oncology 2016 被引用: 1,603

  4. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 被引用: 3,031

  5. Organoid Cultures Derived from Patients with Advanced Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen B. Solomon, James A. Eastham, Ping Chi, Brett S. Carver, Mark A. Rubin, Howard I. Scher, Hans Clevers, Charles L. Sawyers, Yu Chen - Cell 2014 被引用: 1,588

  6. Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Howard Gurney, Elizabeth Hovey, Anthony M. Joshua, Matos Marco, Gavin Marx, Michelle Morris, Siobhan Ng, David Pook, Shahneen Sandhu, Ali Tafreshi, Thean Hsiang Tan, Tsvetanka Tosheva, Livia Andrade, Felipe Melo Cruz, Luiza Dib Batista Bugiato Faria, J. M. L. Figueiredo, Fábio Franke, Andrea Juliana Gomes, Ariel Galapo Kann, Celio Kussumoto, Suelen Patrícia dos Santos Martins, André M. Murad, Hélio Pinczowski, Giovani Thomaz Pioner, Luís Ferreira Pires, Daniel D’Almeida Preto, Gisele Marinho dos Santos, Eduardo Silva, Jamile Silva, Luciano de Souza Viana, Karina Vianna, Adriano Augusto Peclat de Paula, Zhiwen Chen, Kim Chi, Urban Emmenegger, Neil Fleshner, Sunil Parimi, Fred Saad, Francisco Vera-Badillo, Hongqian Guo, Hong Luo, Lulin Ma, Mingxing Qui, Wei Xue, Guo Yonglian, Lei Li, Jinxian Pu, Song Zheng, Qing Zou, Miloš Broďák, Milan Hora, Vladimír Šámal, Vladimír Študent, J Vaňásek, Emmanuelle Bompas, Philippe Barthélémy, Delphine Borchiellini, Aude Fléchon, Hakim Mahammedi, Guilhem Roubaud, Antoine Thiery-Vuillemin, Diégo Tosi, Dominique Spaëth, Carole Hélissey, Martin Boegemann, Susan Feyerabend, Eva Hellmis, Martin Schostak, Gerhardt Attard, Anna Lydon ほか 141 名 - Journal of Clinical Oncology 2023 被引用: 319

  7. Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas W. Griffin, Howard I. Scher, Dana E. Rathkopf - New England Journal of Medicine 2012 被引用: 2,795

  8. Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Howard I. Scher - JAMA Oncology 2018 被引用: 663

  9. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2015 被引用: 1,354

  10. Treatment of Advanced Prostate Cancer

    著者: , , - Annual Review of Medicine 2019 被引用: 727

  11. Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2020 被引用: 254

  12. Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 被引用: 242

  13. Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial

    著者: , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2023 被引用: 199

  14. Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barry S. Taylor, Marc Ladanyi, Diana Mandelker, Liying Zhang, Victor E. Reuter, Philip W. Kantoff, David B. Solit, Michael F. Berger, Charles L. Sawyers, Nikolaus Schultz, Howard I. Scher - JCO Precision Oncology 2017 被引用: 531

  15. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Journal of Cancer 2023 被引用: 157

  16. Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study

    著者: , , , , , , , , , , , , , , , , , , , , - European Urology 2016 被引用: 419

  17. Integrative Clinical Genomics of Advanced Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Andrea Sboner, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 被引用: 591

  18. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Urology 2022 被引用: 118

  19. Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

    著者: , , , , , , , , , , , , , , , , , , - The Lancet 2010 被引用: 1,084

  20. Accelerating precision medicine in metastatic prostate cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cancer 2020 被引用: 77

  21. Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer

    著者: , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2024 被引用: 66

  22. First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy

    著者: , , , , , , , , , , , , , , , , , , , - Cancer Management and Research 2019 被引用: 85

  23. Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 被引用: 67

  24. Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2021 被引用: 106